Is that bear statement been debunk? Or it is true? (the post this reply based on)
that part -> "Liau has indicated that they do not have patient level data for the ECA and Medicenna's ACTUAL MEETING AND APPROVAL WITH THE FDA for their P3 with the hybrid ECA concluded that patient level data was needed for the hybrid ECA including those from external sources. Medicenna created a database with this patient level data for the ECA so they are convered"
Market Data 
Markets 
AI
